BHV-7000, BHV-7000
BHV7000-201
Phase 2 small_molecule active
Quick answer
BHV-7000, BHV-7000 for Refractory Focal Onset Epilepsy is a Phase 2 program (small_molecule) at Biohaven Bioscience Ireland Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Biohaven Bioscience Ireland Limited
- Indication
- Refractory Focal Onset Epilepsy
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active